
Beyond Weight Change: What the SELECT Trial Measured About Semaglutide
Understanding a cardiovascular outcome trial requires more than reading a weight-loss headline. Here is how the 2023 SELECT publication framed its question.
Read articleCompany updates, practical sourcing guides and a closer look at peptide supply.
9 articles

Understanding a cardiovascular outcome trial requires more than reading a weight-loss headline. Here is how the 2023 SELECT publication framed its question.
Read article
A methods-focused look at the shift from solid-supported peptide assembly to automated flow synthesis—and why faster synthesis does not replace characterization.
Read article
From the 2015 discovery paper to later cell-envelope research, teixobactin illustrates why antimicrobial activity and resistance claims need careful context.
Read article
A closer look at a 2023/2024 proof-of-concept study that evaluated peptide activity, stability and permeability together rather than optimizing binding alone.
Read article
A research retrospective on the triple-agonist concept, from discovery work to the 2023 phase 2 obesity trial, with clear limits on interpretation.
Read article
A focused reading of the 2021 and 2022 tirzepatide trials: why study population, comparator and endpoints matter as much as the headline result.
Read article
Bring packaging, delivery and communication requirements into one coordinated sourcing brief.
Read article
Questions to organize your COA request and keep each document connected to the relevant product and batch.
Read article
A practical checklist for sharing product, quantity and documentation requirements with your supplier.
Read article